DeepTek.ai unveils CADe Chest X-Ray AI solution at RSNA2023
IMT News Desk
Augmento X-Ray reduces radiologist workload by an impressive 30-50 per centDeepTek.ai, a leading provider of artificial intelligence (AI) solutions for medical imaging, announced the commercial availability of Augmento X-Ray, a one-of-its-kind CADe Chest X-Ray AI solution powered by US FDA Cleared CXR AI at Radiology Society of North America’s (RSNA) 109th Annual Meeting. Augmento X-Ray is designed to significantly reduce radiologist workload and improve the quality of chest X-ray reporting.Augmento X-Ray reduces radiologist workload by an impressive 30-50 per cent. By seamlessly differentiating chest radiographs without suspicion from those with suspicions, Augmento X-Ray helps reduce the backlog of chest X-rays, improving the radiology workflow and enhancing overall patient care.Powered by the US FDA Cleared AI solution CXR Analyzer, Augmento X-Ray comprehensively covers the entire chest area, providing in-depth analysis for a wide spectrum of lung, pleura and cardiac findings, as well as detection of foreign bodies and hardware within the chest."Augmento X-Ray represents a significant breakthrough in AI-powered medical imaging," said Ajit Patil, Co-Founder of DeepTek. "With the US FDA clearance, Augmento X-Ray is now available in the US market, and we look forward to expanding our reach in this important market, helping healthcare providers deliver better care to their patients.”DeepTek's AI solutions have already made a significant impact in India and the Asia-Pacific region, transforming healthcare by increasing access to quality care at a lower cost. The company's products are deployed in over 500 hospitals and imaging centres, impacting the lives of over a million individuals every year. In Singapore, DeepTek's US FDA-approved platform, Augmento Enterprise, has been chosen as the national radiology AI platform, contributing to improved productivity and quality of care across public hospitals.With its operations in Pune; DeepTek.ai has about 200 members and has partners like TATA Capital, NTT DATA Japan and Shimadzu Asia Pacific.As DeepTek.ai prepares to venture into the US market, the company is set to leverage its new product launch and FDA approvals to make a significant impact on the global healthcare landscape.